Addressing the needs for high-quality and affordable biosimilars

As the biosimilar opportunity unfolds, Omgene is at the right place, at the right time. We are rapidly growing our development, regulatory and clinical expertise, to make therapies affordable to patients, on a global scale

Biosimilar opportunity is set to expand as patents expire on leading biologics and patients demand lower priced drugs. Key therapy areas such as cancer, diabetes and rheumatoid arthritis will spearhead this new wave of biosimilars.